Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Single and Repeat Dose, Double-blind, Placebo Controlled Study to Assess the Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics

NCT00453791 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00453791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00453791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Single and Repeat Dose, Double-blind, Placebo Controlled Study to Assess the Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Terminated
Start date
February 7, 2006
Completion date
April 10, 2006
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma